Recurrent epithelial ovarian cancer: an update on treatment
Recurrent epithelial ovarian cancer: an update on treatment
About this item
Full title
Author / Creator
Publisher
United States: Intellisphere, LLC
Journal title
Language
English
Formats
Publication information
Publisher
United States: Intellisphere, LLC
Subjects
More information
Scope and Contents
Contents
An estimated 85% of patients with epithelial ovarian cancer who achieve a full remission following first-line therapy will develop recurrent disease. Although each subsequent line of therapy is characterized by shorter disease-free intervals, median survival for these patients ranges from 12 months to 24 months. Emerging therapies in the management...
Alternative Titles
Full title
Recurrent epithelial ovarian cancer: an update on treatment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1370633215
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1370633215
Other Identifiers
ISSN
0890-9091
